{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:10:34Z","timestamp":1789380634625,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vaccine.2015.11.069","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T09:46:27Z","timestamp":1450345587000},"page":"516-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Mingzhen","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.11.069_bib0185","doi-asserted-by":"crossref","first-page":"e1003391","DOI":"10.1371\/journal.ppat.1003391","article-title":"Combination of DNA prime\u2013adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model","volume":"9","author":"Kosinska","year":"2013","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1172\/JCI115590","article-title":"Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion","volume":"89","author":"Tsai","year":"1992","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/14760584.1.2.141","article-title":"Recombinant hepatitis B triple antigen vaccine: Hepacare","volume":"1","author":"Zuckerman","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.11.069_bib0210","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0264-410X(01)00312-7","article-title":"Antibody responses to preS components after immunization of children with low doses of BioHepB","volume":"20","author":"Madalinski","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0220","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1016\/j.vaccine.2011.07.098","article-title":"Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination","volume":"29","author":"Zhu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0225","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.vaccine.2006.01.007","article-title":"Comparative immunogenicity of a PreS\/S hepatitis B vaccine in non- and low responders to conventional vaccine","volume":"24","author":"Rendi-Wagner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2013.07.003","article-title":"High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees","volume":"58","author":"Vermeiren","year":"2013","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0235","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1073\/pnas.82.23.8168","article-title":"Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region","volume":"82","author":"Milich","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0240","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.2408336","article-title":"Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen","volume":"228","author":"Milich","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.24325","article-title":"Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells","volume":"54","author":"Echeverria","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0250","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/JVI.69.6.3358-3368.1995","article-title":"Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection","volume":"69","author":"Jung","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0265","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0270","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0275","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.20051639","article-title":"Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses","volume":"203","author":"Boscardin","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0280","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0610383104","article-title":"DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes","volume":"104","author":"Bozzacco","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0285","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molimm.2009.09.026","article-title":"Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation","volume":"47","author":"Singh","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.2009.04933.x","article-title":"The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205\/CD205 receptor on dendritic cells","volume":"1174","author":"Wang","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0295","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1182\/blood-2010-02-268425","article-title":"Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation","volume":"116","author":"Birkholz","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0300","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood-2010-06-288068","article-title":"Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody","volume":"116","author":"Cheong","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0305","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.1019547108","article-title":"Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A","volume":"108","author":"Idoyaga","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0310","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/eji.200939748","article-title":"HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC","volume":"40","author":"Bozzacco","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0320","doi-asserted-by":"crossref","first-page":"13933","DOI":"10.1016\/S0021-9258(18)47884-2","article-title":"Characterization and crystallization of core streptavidin","volume":"262","author":"Pahler","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0325","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.163.4.981","article-title":"Langerhans\u2019 cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody","volume":"163","author":"Kraal","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0330","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/JVI.06353-11","article-title":"Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance","volume":"86","author":"Wu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0335","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.molimm.2008.11.016","article-title":"(DEC-205): a recognition receptor for apoptotic and necrotic self","volume":"46","author":"Shrimpton","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0340","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0345","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.20408","article-title":"Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers","volume":"40","author":"Mancini-Bourgine","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2015.11.069_bib0350","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/S1386-6532(05)80019-8","article-title":"Therapeutic vaccination against chronic hepatitis B virus infection","volume":"34","author":"Michel","year":"2005","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0355","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.11.069_bib0360","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0006-291X(02)02889-9","article-title":"Intravenous injection of naked plasmid DNA encoding hepatitis B virus (HBV) produces HBV and induces humoral immune response in mice","volume":"300","author":"Suzuki","year":"2003","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15017508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T15:32:32Z","timestamp":1653838352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15017508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0264410X15017508"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}